A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2006
11/30/2006	US20060269544 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, BGS42
11/30/2006	US20060269543 Compositions and methods for increasing the stability of antibodies
11/30/2006	US20060269542 Immunoliposome composition for targeting to a HER2 cell receptor
11/30/2006	US20060269541 S.agalactiae antigens I + II
11/30/2006	US20060269540 Targeted cd1d molecules
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269531 Apparatus for generating electrical pulses and methods of using the same
11/30/2006	US20060269529 Modified t lymphocytes and uses therefor
11/30/2006	US20060269528 Production detection and use of transformant cells
11/30/2006	US20060269519 Modulation of cytokine signaling regulators and applications for immunotherapy
11/30/2006	US20060269481 Using cancerous disease modifying antibodies, optionally in combination with one or more chemotherapeutic agents,against the target antigen; improved prognoses; receptor binding assays
11/30/2006	CA2631556A1 Functional epitopes of streptococcus pneumoniae psaa antigen and uses thereof
11/30/2006	CA2610521A1 Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
11/30/2006	CA2610357A1 Antibody or antibody fragment coupled with an immunogenic agent
11/30/2006	CA2610340A1 Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
11/30/2006	CA2609593A1 Anti-cd16 binding molecules
11/30/2006	CA2609480A1 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia
11/30/2006	CA2609276A1 Rapid production of adenovirus-free recombinant adenovirus vectors
11/30/2006	CA2609269A1 Humanized anti-cd40 antibodies and their methods of use
11/30/2006	CA2609173A1 Anti-adhesin 5 fimbrial adhesin-based passive immunoprophylactic
11/30/2006	CA2608835A1 Pretreatment of a biological sample from an autoimmune disease subject
11/30/2006	CA2608522A1 Biomarkers for breast cancer
11/30/2006	CA2545557A1 Stromal antigen-presenting cells and use thereof
11/29/2006	EP1726954A2 Methods of screening for modulators of cell proliferation and methods of diagnosing cell proliferation states
11/29/2006	EP1726656A2 Metalloproteinase-disintegrin family members: SVPH DNAs and polypeptides
11/29/2006	EP1726313A1 Drug for preventing and treating arteriosclerosis
11/29/2006	EP1726311A2 Migration of hematopoietic stem cells and progenitor cells to the liver
11/29/2006	EP1725872A2 Analysis of saccharide vaccines without interference
11/29/2006	EP1725871A1 Separation of unconjugated and conjugated saccharide by solid phase extraction
11/29/2006	EP1725659A2 Natural igm antibodies and inhibitors thereof
11/29/2006	EP1725657A1 Prostatic acid phosphatase antigens
11/29/2006	EP1725586A2 Partially loaded antibodies and methods of their conjugation
11/29/2006	EP1725583A2 Methods for increasing protein polyethylene glycol (peg) conjugation
11/29/2006	EP1725581A1 Novel assay for the separation and quantification of hemagglutinin antigens
11/29/2006	EP1725580A2 Isosteric transformation
11/29/2006	EP1725575A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
11/29/2006	EP1725266A2 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
11/29/2006	EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex
11/29/2006	EP1725260A1 Vaccine for preventing and/or treating a herpes virus infection
11/29/2006	EP1725259A1 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof
11/29/2006	EP1725258A2 Combination vaccines with low dose of hib conjugate
11/29/2006	EP1725257A1 Chicken anemia virus vaccine from cell line
11/29/2006	EP1725256A1 A vaccine formulated for administration to mucosa of the lungs
11/29/2006	EP1725255A2 Polypeptides for inducing a protective immune response against staphlococcus aureus
11/29/2006	EP1725254A2 Anti-cd3 and antigen-specific immunotherapy to treat autoimmunity
11/29/2006	EP1725253A2 Medicaments and methods for treating headache
11/29/2006	EP1725252A2 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine
11/29/2006	EP1725249A2 Monomethylvaline compounds capable of conjugation to ligands
11/29/2006	EP1725111A2 Methods and compositions for inhibition of metastasis
11/29/2006	EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides
11/29/2006	EP1423708B1 Compositions and methods for aa4rp assay
11/29/2006	EP1366080B1 Natural antibodies active against hiv virus
11/29/2006	EP1313504B1 Methods and compositions for inhibiting angiogenesis
11/29/2006	EP1301614B1 Codon-optimized papilloma virus sequences
11/29/2006	EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006	EP1248650B1 Improved dna vaccines for bovine herpesvirus-1
11/29/2006	EP1220911B1 P-glycoproteins and uses thereof
11/29/2006	EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
11/29/2006	EP1198251B1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent
11/29/2006	EP1196598B1 Dsp-3 dual-specificity phosphatase
11/29/2006	EP1162999B1 Vaccine against Streptococcus pneumoniae
11/29/2006	EP1158993B1 Bacterial membrane fractions with adjuvant effect
11/29/2006	EP1141026B1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
11/29/2006	EP1117692B1 Tie2 agonist antibodies
11/29/2006	EP1092027B1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same
11/29/2006	EP1079857B1 Combination meningitidis b/c vaccines
11/29/2006	EP1068331B1 Medicaments for inducing cytotoxic t-cells
11/29/2006	EP1026246B1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
11/29/2006	EP0994721B1 Nerve growth factor as a vaccine adjuvant
11/29/2006	EP0948624B1 Mutants of streptococcal toxin a and methods of use
11/29/2006	EP0937251B1 Purification of antigen-specific t cells
11/29/2006	EP0918848B1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/29/2006	EP0837936B1 New immunoregulatory protein lst-1
11/29/2006	EP0821695B1 Antibody purification by low-ph hydrophobic interaction chromatography
11/29/2006	EP0719336B1 Modified plant viruses as vectors of heterologous peptides
11/29/2006	EP0556292B2 Hepatitis c virus asialoglycoproteins
11/29/2006	CN1871355A Method for the recovery of non-segmented, nagative-stranded rna viruses from cdna
11/29/2006	CN1871259A Improved antibodies having altered effector function and methods for making the same
11/29/2006	CN1871028A Method for treating pain by administering a nerve growth factor antagonist and an NSAID and composition containing
11/29/2006	CN1871027A 疫苗 Vaccine
11/29/2006	CN1871026A 黄病毒疫苗 Flavivirus vaccines
11/29/2006	CN1871025A Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS)
11/29/2006	CN1869243A Recombined porcine adenovirus based viral vaccines and vectors
11/29/2006	CN1869234A Recombination newcastle disease LaSota weak virus vaccine for expressing poultry influenza virus H5 sub type HA protein
11/29/2006	CN1869207A Rat antihuman macrephage migration inhibiting factor monoclone antibody and its application
11/29/2006	CN1869070A High efficiency low poison immune toxin and its preparation method and application
11/29/2006	CN1869069A Recombination enterovirus 71 type neutralization antibudy and its use
11/29/2006	CN1869066A Tumour antigen protein and tumour antigen peptide
11/29/2006	CN1869064A Tumour antigen protein and tumour antigen peptide
11/29/2006	CN1868545A Improved vaccines
11/29/2006	CN1286976C Interferon-alpha/beta binding protein, its preparation and use
11/29/2006	CN1286969C Stabilizing diluent for polypeptides and antigens
11/28/2006	US7141662 Diagnosis using antibodies; culture product
11/28/2006	US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006	US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141550 Intra-tumoral administration of IL-12 encoding nucleic acid molecules
11/28/2006	US7141548 controlling dietetic fats and,or antilipemic agents ; reducing blood lipid concentration
11/28/2006	US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006	US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments

1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 1823